Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype KE Smedby, H Hjalgrim, J Askling, ET Chang, H Gregersen, ... Journal of the National Cancer Institute 98 (1), 51-60, 2006 | 496 | 2006 |
UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M‐proteins and the management of monoclonal gammopathy of … J Bird, J Behrens, J Westin, I Turesson, M Drayson, R Beetham, S D’Sa, ... British journal of haematology 147 (1), 22-42, 2009 | 189 | 2009 |
Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial UH Mellqvist, P Gimsing, O Hjertner, S Lenhoff, E Laane, K Remes, ... Blood, The Journal of the American Society of Hematology 121 (23), 4647-4654, 2013 | 176 | 2013 |
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network NWCJ van de Donk, A Palumbo, HE Johnsen, M Engelhardt, F Gay, ... haematologica 99 (6), 984, 2014 | 165 | 2014 |
Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised … P Gimsing, K Carlson, I Turesson, P Fayers, A Waage, A Vangsted, ... The lancet oncology 11 (10), 973-982, 2010 | 134 | 2010 |
The impact of M-component type and immunoglobulin concentration on the risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance H Gregersen, L Mellemkjær, JS Ibsen, JF Dahlerup, L Thomassen, ... Haematologica 86 (11), 1172-1179, 2001 | 90 | 2001 |
Third generation oral contraceptives and heritable thrombophilia as risk factors of non-fatal venous thromboembolism BS Andersen, J Olsen, GL Nielsen, FH Steffensen, HT Sørensen, J Baech, ... Thrombosis and haemostasis 59 (01), 28-31, 1998 | 81 | 1998 |
Smoldering multiple myeloma risk factors for progression: a Danish population‐based cohort study R Sørrig, TW Klausen, M Salomo, AJ Vangsted, B Østergaard, ... European journal of haematology 97 (3), 303-309, 2016 | 67 | 2016 |
The data quality of haematological malignancy ICD-10 diagnoses in a population-based hospital discharge registry M Nørgaard, MV Skriver, H Gregersen, G Pedersen, HC Schønheyder, ... European journal of cancer prevention 14 (3), 201-206, 2005 | 67 | 2005 |
Mortality and causes of death in patients with monoclonal gammopathy of undetermined significance H Gregersen, JS Ibsen, L Mellemkjœr, JF Dahlerup, JH Olsen, ... British journal of haematology 112 (2), 353-357, 2001 | 67 | 2001 |
Causes of early death in multiple myeloma patients who are ineligible for high-dose therapy with hematopoietic stem cell support: A study based on the nationwide Danish Myeloma … MO Holmström, P Gimsing, N Abildgaard, NF Andersen, C Helleberg, ... American journal of hematology 90 (4), E73-4, 2015 | 59 | 2015 |
The risk of bacteremia in patients with monoclonal gammopathy of undetermined significance H Gregersen, KM Madsen, HT Sørensen, HC Schønheyder, JS Ibsen, ... European journal of haematology 61 (2), 140-144, 1998 | 58 | 1998 |
Fracture risk in patients with monoclonal gammopathy of undetermined significance H Gregersen, P Jensen, M Gislum, B Jørgensen, HT Sørensen, ... British journal of haematology 135 (1), 62-67, 2006 | 56 | 2006 |
The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population‐based study H Gregersen, AJ Vangsted, N Abildgaard, NF Andersen, RS Pedersen, ... Cancer medicine 6 (7), 1807-1816, 2017 | 54 | 2017 |
Monoclonal gammopathy of undetermined significance and risk of venous thromboembolism H Gregersen, M Nørgaard, MT Severinsen, MC Engebjerg, P Jensen, ... European journal of haematology 86 (2), 129-134, 2011 | 45 | 2011 |
Cancer risk in patients with monoclonal gammopathy of undetermined significance H Gregersen, L Mellemkjær, J Salling Ibsen, HT Sørensen, JH Olsen, ... American journal of hematology 63 (1), 1-6, 2000 | 45 | 2000 |
The Danish national multiple myeloma registry P Gimsing, MO Holmström, TW Klausen, NF Andersen, H Gregersen, ... Clinical epidemiology, 583-587, 2016 | 43 | 2016 |
The polymorphism IL-1β T-31C is associated with a longer overall survival in patients with multiple myeloma undergoing auto-SCT AJ Vangsted, TW Klausen, W Ruminski, P Gimsing, NF Andersen, ... Bone Marrow Transplantation 43 (7), 539-545, 2009 | 43 | 2009 |
Vascular endothelial growth factor (VEGF) gene polymorphisms may influence the efficacy of thalidomide in multiple myeloma NF Andersen, U Vogel, TW Klausen, P Gimsing, H Gregersen, ... International Journal of Cancer 131 (5), E636-E642, 2012 | 39 | 2012 |
Multiple myeloma following an episode of community acquired pneumococcal bacteraemia or meningitis H GREGERSEN, G PEDERSEN, N SVENDSEN, AM Thulstrup, ... Apmis 109 (11), 797-800, 2001 | 39 | 2001 |